218 related articles for article (PubMed ID: 32683537)
1. Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.
Ragazzi M; Torricelli F; Donati B; Ciarrocchi A; de Biase D; Tallini G; Zanetti E; Bisagni A; Kuhn E; Giordano D; Frasoldati A; Piana S
Virchows Arch; 2021 Feb; 478(2):265-281. PubMed ID: 32683537
[TBL] [Abstract][Full Text] [Related]
2. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
Teng L; Deng W; Lu J; Zhang J; Ren X; Duan H; Chuai S; Duan F; Gao W; Lu T; Wu H; Liang Z
Oncotarget; 2017 Mar; 8(13):22023-22033. PubMed ID: 28423545
[TBL] [Abstract][Full Text] [Related]
3. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon.
Xu B; Scognamiglio T; Cohen PR; Prasad ML; Hasanovic A; Tuttle RM; Katabi N; Ghossein RA
Hum Pathol; 2017 Jul; 65():133-139. PubMed ID: 28552827
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
6. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review.
Lee YS; Kim Y; Jeon S; Bae JS; Jung SL; Jung CK
Int J Clin Exp Pathol; 2015; 8(7):7988-97. PubMed ID: 26339365
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
[TBL] [Abstract][Full Text] [Related]
8. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
[TBL] [Abstract][Full Text] [Related]
10. Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study.
Kuhn E; Ragazzi M; Ciarrocchi A; Torricelli F; de Biase D; Zanetti E; Bisagni A; Corrado S; Uccella S; La Rosa S; Bongiovanni M; Losito S; Piana S
Mod Pathol; 2019 Jun; 32(6):787-798. PubMed ID: 30723294
[TBL] [Abstract][Full Text] [Related]
11. Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.
Sykorova V; Dvorakova S; Vcelak J; Vaclavikova E; Halkova T; Kodetova D; Lastuvka P; Betka J; Vlcek P; Reboun M; Katra R; Bendlova B
Anticancer Res; 2015 Apr; 35(4):2029-36. PubMed ID: 25862857
[TBL] [Abstract][Full Text] [Related]
12. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
13. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
14. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
[TBL] [Abstract][Full Text] [Related]
16. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
[TBL] [Abstract][Full Text] [Related]
17. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
Xu B; Tuttle RM; Sabra MM; Ganly I; Ghossein R
Thyroid; 2017 May; 27(5):632-640. PubMed ID: 28049366
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid carcinoma with rhabdoid phenotype: An unusual case and a comprehensive review.
Bansal S; Sancheti S; Kaur S; Somal P; Kalra SK; Sali AP
Diagn Cytopathol; 2020 Nov; 48(11):1125-1130. PubMed ID: 32515545
[TBL] [Abstract][Full Text] [Related]
19. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
20. Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer.
Guo LC; Zhu WD; Ma XY; Ni H; Zhong EJ; Shao YW; Yu J; Gu DM; Ji SD; Xu HD; Ji C; Yang JM; Zhang Y
Cancer Biol Ther; 2019; 20(3):240-246. PubMed ID: 30252567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
